Turka, L A <br/><br/>
T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Nov 1992 
 - 11102-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0027-8424 
<br/><br/><label>Standard No.: </label>10.1073/pnas.89.22.11102  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--immunology<br/>Antigens, CD--immunology<br/>Antigens, Differentiation, T-Lymphocyte--immunology<br/>CD28 Antigens<br/>Cells, Cultured<br/>Graft Rejection<br/>Graft Survival<br/>Heart Transplantation--immunology<br/>Ligands<br/>Lymphocyte Activation<br/>Major Histocompatibility Complex<br/>Male<br/>Rats<br/>Rats, Inbred BN<br/>Rats, Inbred Lew<br/>Rats, Sprague-Dawley<br/>Receptors, Antigen, T-Cell--immunology<br/>Receptors, Cell Surface--immunology<br/>T-Lymphocytes--immunology<br/>Thymectomy<br/>Transplantation, Homologous